Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

biomarkers Press Releases

  + XML/RSS  



By Visiongain
LONDON, UK, 18TH July 2014: A new report by visiongain calculates that the global prostate cancer therapeutics market will reach $7bn in 2014 with revenue showing strong growth to 2024.

By SMi Group
Imaging allows us to answer questions that we did not know the answer to before. For example, it can help determine the composition of the tumour, clinical evaluation of patients and evaluation of new treatments.

By Aseptika Ltd (Activ8rlives)
Aseptika Ltd, is developing home-based rapid and quantitative test for bacterial respiratory infections in patients with Cystic Fibrosis (CF). Volunteers from Papworth Hospital NHS Foundation Trust are now participating in the clinical trial.

By SMi Group
It will bring you the latest developments from toxicity testing to compound screening and first-in-man studies to companion diagnostic assays, stay competitive with fresh insights from companies at the cutting edge of biopharmaceutical development.

By SMi Group
Drawing on advances in genomics, translational medicine and clinical trial design, SMi’s sixth annual Biomarkers Summit held on 16th &17th January 2013 London brings you the latest developments in this field.

By SMi Group
Paving the way of using AD biomarkers as supportive evidence of disease modifying treatment effects

By SMi Group
Technical developments in Immuno-PET and TKI-PET and their clinical potential

By Cambridge healthtech Institute
CHI confirms new speakers for its keynote session on cancer clinical trials in the era of personalized medicine lead by Roche Holding AG, UCSF Helen Diller Family Comprehensive Cancer Center, and Samuel Oschin Comprehensive Cancer Institute.

All Press Releases

By Visiongain
LONDON, UK, 18TH July 2014: A new report by visiongain calculates that the global prostate cancer therapeutics market will reach $7bn in 2014 with revenue showing strong growth to 2024.

By SBH Sciences
(Natick, MA, USA)  July 1, 2014. SBH Sciences, an innovative pre-clinical contract research organization, announced today that they have increased their service offerings through the addition of a newly introduced immunoassay-testing platform, the...

By Pathology Diagnostics Ltd
Immunotherapies were one of the highlights of the ASCO 2014 meeting.

By Pharmatech Inc.
Exciting new opportunities present themselves for cancer patients and the clinical trials industry.

By SMi Group
Imaging allows us to answer questions that we did not know the answer to before. For example, it can help determine the composition of the tumour, clinical evaluation of patients and evaluation of new treatments.

By Kalorama Information
The global medical biomarker market is valued at about $25.9 billion for 2013, an increase of 10.2% since last year, according to an estimate from Kalorama Information.

By Aseptika Ltd
Aseptika today announced that it has been granted a patent in the UK protecting its invention for a test for lung infections.

By Burke Medical Research Institute
Ava Weibman won a $4,000 Summer Student Fellowship from the Parkinson’s Disease Foundation (PDF) and a 10-week laboratory experience in Burke Medical Research Institute’s Laboratory for Neuronal Specification.

By Activ8rlives (Aseptika Ltd)
Activ8rlives announces a novel motivational programme for its users, utilising its integrated medals system, to reward being consistently active.

By Aseptika Ltd (Activ8rlives)
Aseptika Ltd, is developing home-based rapid and quantitative test for bacterial respiratory infections in patients with Cystic Fibrosis (CF). Volunteers from Papworth Hospital NHS Foundation Trust are now participating in the clinical trial.

By SMi Group
It will bring you the latest developments from toxicity testing to compound screening and first-in-man studies to companion diagnostic assays, stay competitive with fresh insights from companies at the cutting edge of biopharmaceutical development.

By SMi Group
Drawing on advances in genomics, translational medicine and clinical trial design, SMi’s sixth annual Biomarkers Summit held on 16th &17th January 2013 London brings you the latest developments in this field.

By Biotech Support Group
NuGel™ Glycoprotein Enrichment PBA product is ideal for mining glycoproteins and represents a new paradigm for biomarker discovery from glycoproteins.

By Visiongain
A new report by visiongain predicts that the global market for biomarkers will be worth $15.29 billion in 2012.

By SMi Group
Paving the way of using AD biomarkers as supportive evidence of disease modifying treatment effects

By Rosa & Co
Modeling analysis enables development of clinical markers for beta cell mass.

By SMi Group
Technical developments in Immuno-PET and TKI-PET and their clinical potential

By SMi Group
Join us on the 14th and 15th March 2012 at the Copthorne Tara Hotel to gain top tips from experienced industry figures discussing ways in which to develop drugs in a clever way with reduced production time

By Camrbridge Healthtech Institute
Cambridge Healthtech Institute's 8th Annual Translational Science Event Only 7 Weeks Away! Advance Registration Discount expires Friday, January 13th!

By Cambridge Healthtech Institute
Cambridge Healthtech Institute to Hold Inaugurual Next-Generation Pathology Symposia at 19th International Molecular Med Tri-CON 2012.

By SMi Group
This Biomarkers Summit 2012 will provide a unique opportunity for debate and problem solving for key challenges facing the biomarkers fields as well as hearing from leading experts in this rapidly-evolving area.

By GTC Conference
Pharmaceutical industry decision-makers, scientists, researchers, technology developers and investors will gather in one location at GTC’s Biomarker Summit 2012, March 15-16 in San Diego, CA.

By Reportsnreports
Datamonitor’s “Hot Topics: Impact of Biomarkers in Alzheimer's Disease - Dx-Rx collaboration paves the way for personalized medicine” is now available at ReportsnReports.com.

By Cambridge healthtech Institute
CHI confirms new speakers for its keynote session on cancer clinical trials in the era of personalized medicine lead by Roche Holding AG, UCSF Helen Diller Family Comprehensive Cancer Center, and Samuel Oschin Comprehensive Cancer Institute.

By rgunnam
The report provides the the major market drivers, restraints, and opportunities for the global biomarker market

By SMi Group
This event will bring together senior scientists, medical directors, Biostatisticians to address and find solutions to current issues in biomarker efficiency and strategies

By Reportstack
Reportstack.com has announced the addition of Insight Pharma's 'Commercializing Biomarkers in Therapeutic and Diagnostic Applications' to their offering

By SMi Group Ltd
SMi Group is proud to announce its 10th annual Clinical Trials in CNS conference, which will be held in London on 23rd & 24th November 2011.

By SMi Group Ltd
SMi Group is proud to announce its 3rd annual Biomarkers in Clinical Trials conference, which will be held in London on 19th and 20th September 2011.

By Tecan Trading AG
A new automated sample preparation system based on Tecan’s Freedom EVO® 200 liquid handling platform has been developed for proteomic biomarker discovery and validation in collaboration with the Translational Genomics Research Institute (TGen)

By Insight Pharma Reports
New Report Featuring 8 Expert Interviews and Over 160 Companies

By SMi Group
SMi’s Biobanking conference, taking place in London, 11th & 12th July 2011, is the perfect opportunity to network with the industry’s leading figures and contribute to the successful future of drug discovery.

By David Eastman, CEO
Dr. David H. Farrell, GT’s Founder and CSO will present scientific data related to his three decades of research in human blood fibrinogen, hemostasis and thrombosis at the American Heart Association Conf. in Chicago, IL, April 28-30, 2011.

By SMi Group
Biobanking 2011, taking place in London, July 2011, acts as a bridge between the worlds’ leading academia and pharma; this is the perfect forum to network with a targeted delegate audience and contribute to the successful future of drug discovery.

By Mark Warne, CEO
Investment in Queen Mary, University of London spin-out to fund growth strategy

By SciClips
A database of 29,000 unique biomarkers (for more than 1800 human diseases), which are manually extracted from US patent/WO (PCT) publications and PubMed abstracts.

By IQPC
As part of the preparation for the Global Companion Diagnostics Forum IQPC have put together a short survey on Companion Diagnostics issues.

By reports-research.com
GBI Research, the leading business intelligence provider, has released its latest report, Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer -

By Bharatbook
Bharatbook added a new report on "Cancer Profiling and Pathways: Technologies and Global Markets" gives a detailed overview and thorough analysis and insight of the present and future cancer profiling and pathways.

By Kalorama Information
The histology test segment is one of the fastest growing sectors in the IVD industry. The growing market has attracted many new entrants and competition has intensified. Histology/cytology will grow annually 5-10% over the next 5-10 years.

By Kalorama Information
Given the unfortunate statistics of cancer in the developed world, innovation is a must. Growth rates in cancer testing tends to be higher than in other IVD fields. As cancer becomes more treatable, diagnostics are finding multiple expanded roles.

By J.Roberts
This report describes different types of biomarkers and their discovery using various “-omics” technologies such as proteomics and metabolomics.

By Alto Marketing
‘Screening for novel oncology biomarker panels using both DNA and protein microarrays’

By Van Andel Institute
Working with researchers from the University of Michigan and Indiana University, Van Andel Institute investigators have developed a method that could be used to predict whether pancreatic cysts are benign or are precursors to invasive cancer.

By Randox Pharma Services
Randox Laboratories has been supplying the world’s leading Contract Research Organisations (CRO), Pharmaceutical and Biotech companies for over 27 years with the ‘tools’ required to develop high quality pharmaceuticals.

By Bharatbook
Bharatbook.com added a new report on "Stakeholder Opinions: Biomarkers in Rheumatology - Awaiting the next step towards personalized medicine" into its market report catalogue for reselling.

By Brandwidth Solutions LLC
Axela Inc. introduces panelPlus Multiplex Sensors and an introductory assay menu for oncology, cardiology and infectious disease research. This innovative assay format provides the industry’s first real-time, user configurable multiplex assays.

By GTCbio
The conference is in session from October 1-2, 2009 in Lisbon, Portugal with topics ranging from how to decrease the cost of drug discovery to translational research.

By bharatbook.com
Cancer Bundle offers a 15% discount off the total transaction price for the following reports being purchased simultaneously

By GTCbio
Dr. Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center in Seattle, WA will give the keynote address on the discovery and development of biomarkers at the 2nd annual Oncology Biomarkers Conference on Jan. 19-20 in Miami, Florida



Page:

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share